No, Medicare does not cover bright-light therapy for dementia. Bright-light therapy means scheduled time near a bright lamp meant to support sleep and mood. The Centers for Medicare & Medicaid Services has no national rule granting payment for this use, as shown in its coverage database entry. Northwood's January 2025 Medicare policy treats the home light box, code E0203, as not reasonable and necessary, explained in the Medicare policy document.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Official resources:
- Explore the official data from CMS — Use this primary source to review the underlying data.
- Read the official guidance from Medicare — Use this primary source to verify the official guidance.
Table of Contents
- Why Medicare has no payment path
- What the strongest trials show
- Where tailored daytime lighting helped
- How to use coverage and cash wisely
Why Medicare has no payment path
DementiaCareCentral states no FDA decision establishes light therapy as viable dementia treatment. That leaves Medicare with no dementia basis to pay for a home lamp.
The related federal rule is narrow but telling. Since October 24, 2006, CMS has made infrared and near-infrared therapy non-covered. Bright lamps use different light, yet they have no favorable national rule to take its place.
What the strongest trials show
An updated Cochrane review pooled 11 trials in dementia. It found no effect on cognition, daily activities, sleep, agitation, or psychiatric symptoms. The authors found insufficient evidence to recommend bright-light therapy, summarized in the Cochrane evidence summary. A 2023 meta-analysis also pooled 11 randomized trials.
It found fewer nighttime awakenings with light therapy. It found no significant effect on agitation or depression, according to the American Journal of Alzheimer's Disease and Other Dementias via Medscape MEDLINE. Together, the reviews do not support buying a lamp to improve thinking or calm behavior. Any sleep gain looks uncertain for routine home use.
Where tailored daytime lighting helped
Figueiro and colleagues tested a different approach in nursing homes. They changed daytime room lighting for residents with Alzheimer's and related dementias. Nighttime sleep efficiency improved, while wandering, evening agitation, and depression scores fell, reported in the full study report.
This was built-in lighting, not a small box used on demand. Staff controlled timing and exposure during the day. Families cannot assume the same result from a bedside lamp.
How to use coverage and cash wisely
The Alzheimer's Association urges non-drug approaches first for behavior symptoms. It notes FDA has approved no drugs for those non-cognitive symptoms.
Light remains a self-pay adjunct, not a billed dementia therapy, as reported via ScienceDaily in July 2018. Medicare.gov points families toward covered care instead. Use covered visits for medical causes of poor sleep and behavior.
- Use a wellness visit for medical evaluation and cognitive assessment.
- Ask what time-limited skilled care applies after a qualifying medical need.
- Buy a lamp only as an extra after medical review, with a clear return option.





